ArticleAnnals of hematology2023

Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the "RTL" (regional Tuscan lymphoma network).

Emanuele Cencini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.